Is a 100 mg intravenous (IV) bolus of ropivacaine hazardous in an adult?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board

Educational purpose only • Exercise caution as content is pending human review

Article Review Status

Submitted

Under Review

Approved

Last updated: February 18, 2026 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Related Questions

What is the difference between ropivacaine (local anesthetic) and bupivacaine (local anesthetic) in terms of usage and efficacy?

Can ropivacaine (local anesthetic) toxicity occur with nerve catheter use?

Can an erector spinae plane (ESP) block be performed with a concentration of ropivacaine higher than 0.25%?

What is the recommended concentration of ropivacaine (a local anesthetic) for peripheral nerve blocks?

Can patients with ropivacaine (amide-type local anesthetic) nerve block experience toxicity?

In a 66-year-old man on chronic low-dose aspirin after aneurysm repair who presents with an isolated olecranon fracture requiring operative fixation, should we proceed with surgery while continuing aspirin?

How should I manage an acute bacterial exacerbation of chronic sinusitis, including first‑line antibiotics, intranasal corticosteroids, and adjunctive therapies?

What is the recommended intratympanic steroid treatment protocol for idiopathic sudden sensorineural hearing loss, including drug choice, dosage, frequency, contraindications, and follow‑up?

How should postoperative surgical subcutaneous emphysema presenting with neck or chest wall swelling and crepitus be evaluated and treated?

Is a total dose of 100 mg ropivacaine administered to an average adult over 20 hours toxic?

In a 43‑year‑old woman who received a red blood cell transfusion 14 days ago and now presents with fever, anemia (hemoglobin 7 g/dL), leukopenia (total leukocyte count 2,300/µL) with neutropenia (30% neutrophils), and mild hyperbilirubinemia (bilirubin 1.4 mg/dL), what are the differential diagnoses and appropriate management?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.